Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
: Kauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV
: 2012
: Acta Oncologica
: 5
: 51
: 5
: 636
: 644
: 9
: 1651-226X
: 1651-226X
DOI: https://doi.org/10.3109/0284186X.2011.643822
Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen
Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.
Read More: http://informahealthcare.com/toc/onc/51/5
Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen
Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.
Read More: http://informahealthcare.com/toc/onc/51/5
Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen
Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.
Read More: http://informahealthcare.com/toc/onc/51/5
UTU Research Portal